Voprosy meditsinskoi khimii (ISSN 0042-8809)

Excretion of catecholamines and DOPA in lipid metabolism disorders

   
Frolova I.A., Oleneva V.A., Paramonova E.G., Volkova I.S., Sirota I.I.
PubMed Id: 595486
Year: 1977 vol: 23  issue:6  pages: 797-803
Abstract: Excretion of catecholamines and DOPA was impaired in patients with metabolic-alimentary obesity, with ischemic disease of heart, with atherosclerosis and excessive weight. Distinct decrease in content of adrenaline, noradrenaline and DOPA was observed in patients with obesity; the phenomenon was less pronounced in ischemic disease of heart, mainly in aged patients. Correlation was found between the rate of excretion of catecholamines and DOPA and the extent of hyperlipidemia. Dietetics did not normalize completely the impairments studied. Additional administration of pyridoxine caused a favorable effect.
Download PDF:
Reference: Frolova I.A., Oleneva V.A., Paramonova E.G., Volkova I.S., Sirota I.I., Excretion of catecholamines and DOPA in lipid metabolism disorders, Voprosy meditsinskoi khimii, 1977, vol: 23(6), 797-803.
References
 1985(Vol:31)
 1984(Vol:30)
 1983(Vol:29)
 1982(Vol:28)
 1981(Vol:27)
 1980(Vol:26)
 1979(Vol:25)
 1978(Vol:24)
 1977(Vol:23)
 1976(Vol:22)